Pharmacological effects of epidermal growth factor (EGF): With focus on the urinary and gastrointestinal tracts

APMIS, Supplement

Volumn 107, Issue 93, 1999, Pages 5-42

  Vinter Jensen, Lars ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; EPIDERMAL GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CELL PROLIFERATION; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; DRUG RESEARCH; DRUG SENSITIVITY; EPITHELIUM CELL; FEMALE; GROWTH REGULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH ACID SECRETION; SWINE; TRANSGENIC ANIMAL; URINARY TRACT; ANIMAL; DIGESTIVE SYSTEM; DRUG EFFECT; HUMAN; REVIEW; SPECIES DIFFERENCE;

ANIMALS; DIGESTIVE SYSTEM; EPIDERMAL GROWTH FACTOR; HUMANS; SPECIES SPECIFICITY; URINARY TRACT;

EID: 0032602580     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.1999.tb05690.x     Document Type: Article

References (311)

1. Elder JB, Ganguli PC, Gillespie IE, Gerring EL, Gregory H. Effect of urogastrone on gastric secretion and plasma gastrin levels in normal subjects. Gut 1975;16:887-893.
2. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 1962;237:1555-1562.
3. Gregory H. Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 1975;257:325-327.
4. Moore GPM, Panaretto BA, Robertson D. Epidermal growth factor causes shedding of the fleece of Merino sheep. Search 1981;12:128-129.
5. Gray JS, Wieczoroski K, Ivy AC. Inhibition of gastric secretion in man with urogastrone. Am J Dig Dis 1940;7:513-515.
6. Gray JS, Wieczorowski E, Ivy AC. Inhibition of gastric secretion in man with urogastrone. Science 1939;89:489-490.
7. Sandweiss DJ, Saltzstein C. The prevention or healing of experimental peptic ulcer in Mann-Williamson dogs with the anterior pituitary-like hormone (Antuitrin-S). Am J Dig Dis Nutr 1938;5:24-30.
8. Sandweiss DJ. The immunizing effect of the anti-ulcer factor in normal human urine (Anthelone) against the experimental gastrojejunal (peptic) ulcers in dogs. Gastroenterology 1943;1:965-969.
9. Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995;19:183-232.
10. Prigent SA, Lemoine NR. The type 1 (EGFR-related) family of growth factor receptors and their ligands. Prog Growth Factor Res 1992;4:1-24.
11. Coussens L, Yang-Feng TL, Liao Y-C, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 1985;230:1132-1139.
12. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci U S A 1989;86:9193-9197.
13. Plowman GD, Culouscou J-M, Whitney GS, Green JM, Carlton GW, Foy L, Neubauer MG, Shoyab M. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci U S A 1993;90:1746-1750.
14. Earp HS, Dawson TL, Li X, Yu H. Heterodimerization and functional interaction between EGF receptor family members: A new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat 1995;35:115-132.
15. Carpenter G, Wahl MI. The Epidermal Growth Factor Family. In Sporn M and Roberts AB, editors. Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors I and II. Berlin: Springer-Verlag, 1990; 69-171
16. Burgess AW. Epidermal growth factor and transforming growth factor alpha. Br Med Bull 1989;45:401-424.
17. Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem 1990;265:7709-7712.
18. Derynck R, Roberts AB, Winkler ME, Chen EY, Goeddel DV. Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell 1984;38:287-297.
19. Derynck R. The physiology of transforming growth factor-alpha. Adv Cancer Res 1992;58:27-52.
20. Higashiyama S, Lau K, Besner GE, Abraham JA, Klagsbrun M. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem 1992;267:6205-6212.
21. Shoyab M, Plowman GD, McDonald VL, Bradley JG, Todaro GJ. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 1989;243:1074-1076.
22. erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells. J Biol Chem 1993;268:2924-2931.
23. Shing Y, Christofori G, Hanahan D, Ono Y, Sasada R, Igarashi K, Folkman J. Betacellulin: a mitogen from pancreatic βcell tumors. Science 1993;259:1604-1607.
24. Sasada R, Ono Y, Taniyama Y, Shing Y, Folkman J, Igarashi K. Cloning and expression of cDNA encoding human betacellulin, a new member of the EGF family. Biochem Biophys Res Commun 1993;190;1173-1179.
25. Toyoda H, Komurasaki T, Uchida D, Takayama Y, Isobe T, Okuyama T, Hanada K. Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem 1995;270:7495-7500.
26. Twardzik DR, Ranchalis JE, Moss B, Todaro GJ. Vaccinia growth factor: newest member of the family of growth modulators which utilize the membrane receptor for EGF. Acta Neurochir Suppl Wien 1987;41:104-109.
27. Lin YZ, Ke XH, Tam JP. Synthesis and structure-activity study of myxoma virus growth factor. Biochemistry 1991;30:3310-3314.
28. Chang W, Upton C, Hu SL, Purchio AF, McFadden G. The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha. Mol Cell Biol 1987;7:535-540.
29. Jørgensen PE, Rasmussen TN, Skov Olsen P, Raaberg L, Seier Poulsen S, Nexø E. Renal uptake and excretion of epidermal growth factor from plasma in the rat. Regul Pept 1990;28:273-281.
30. Mattila A-L, Viinikka L, Saario I, Perheentupa J. Human epidermal growth factor: renal production and absence from plasma. Regul Pept 1988;23:89-93.
31. Miettinen PJ, Berger JE, Meneses J, Phung Y, Pedersen RA, Werb Z, Derynck R. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 1995;376:337-341.
32. Threadgill DW, Dlugosz AA, Hanssen LA, Tennembaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, Barnard JA, Yaspa SH, Coffey RJ, Magnuson T. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype. Science 1995;269:230-234.
33. Sibilia M, Wagnar EF. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 1995;269:234-238.
34. Lee K-F, Simon H, Chen H, Bates B, Hung M-C, Hauser C. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 1995;378:394-397.
35. Gassmann M, Casagranda F, Orloll D, Simon H, Lai C, Klein R, Lemke G.. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 1995;378:390-394.
36. Mayer D, Birchmeier C. Multiple essential functions of neuregulin in development. Nature 1995;378:386-390.
37. Mann GB, Fowler KJ, Gabriel A, Nice EC, Williams RL, Dunn AR. Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 1993;73:249-261.
38. Luetteke N C, Qiu T H, Pfeiffer R L, Oliver P, Smithies O, Lee DC. TGFα deficiency results in hair follicle and eye abnormalities in targeted and Waved-1 mice. Cell 1993;73:263-278.
39. Jhappan C, Stahle C, Harkins RN, Fausto N, Schmidt GH, Merlino GT. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990;61:1137-1146.
40. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC. Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia and carcinoma of the breast. Cell 1990;61:1121-1135.
41. Matsui Y, Halter SA, Holt JT, Hogan BL, Coffey RJ. Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice. Cell 1990;61:1147-1155.
42. Strayer DS, Shijun Y, Schwartz MS. Epidermal growth factor-like growth factors. I. Breast malignancies and other epithelial proliferations in transgenic mice. Lab Invest 1993;69:660-673.
43. Webber EM, Wu JC, Wang L, Merlino G, Fausto N. Overexpression of transforming growth factor-α causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol 1994;145:398-408.
44. Lee GH, Merlino G, Fausto N. Development of liver tumors in transforming growth factor α transgenic mice. Cancer Res 1992;52:5162-5170.
45. Takagi H, Sharp R, Hammermeister C, Goodrow T, Bradley MO, Fausto N, Merlino G. Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice. Cancer Res 1992;52:5171-5177.
46. Wang X-J, Greenhalgh DA, Eckhardt JN, Rothnagel JA, Roop DR. Epidermal expression of transforming growth factor α in transgenic mice: Induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression. Mol Carcino 1994;10:15-22.
47. Lowden DA, Lindemann GW, Merlino G, Barash BD, Calvet JP, Gattone VH. Renal cysts in transgenic mice expressing transforming growth factor-alpha. J Lab Clin Med 1994;124:386-394.
48. Korfhagen TR, Swantz RJ, Wert SE, McCarty JM, Kerlakian CB, Glasser SW, Whitsett JA. Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. J Clin Invest 1994;93:1691-1699.
49. Bockman DE, Merlino G. Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor α. Gastroenterology 1992;103:1883-1892.
50. Dempsey PJ, Goldenring JR, Soroko CJ, Modlin IM, McClure RW, Lind CD, Ahlquist DA, Pittelkow MR, Lee DC, Sandgren E Page DL, Coffey RJ. Possible role of transforming growth factor α in the pathogenesis of Menetrier's disease: Supportive evidence from humans and transgenic mice. Gastroenterology 1992;103:1950-1963.
51. Takagi H, Jhappan C, Sharp R, Merline G. Hypertrophic gastropathy resembling Menetrier's disease in transgenic mice overexpressing transforming growth factor α in the stomach. J Clin Invest 1992;90:1161-1167.
52. Merlino GT, Stahle C, Jhappan C, Linton R, Mahon KA, Willingham MC. Inactivation of a sperm motility gene by insertion of an epidermal growth factor receptor transgene whose product is overexpressed and compartmentalized during spermatogenesis. Genes Dev 1991;5:1395-1406.
53. Jhappan C, Stahle C, Wolff M, Merlino G, Pastan I. An epidermal growth factor receptor promoter construct selectively expresses in the thymus and spleen of transgenic mice. Cell Immunol 1993;149:99-106.
54. Jørgensen PE, Poulsen SS, Nexø E. Distribution of i.v. administered epidermal growth factor in the rat. Regul Pept 1988;23:161-169.
55. Kim DC, Sugiyama Y, Fuwa T, Sakamoto S, Iga T, Hanano M. Kinetic analysis of the elimination process of human epidermal growth factor (hEGF) in rats. Biochem Pharmacol 1989;38:241-249.
56. Hwang DL, Lev Ran A. Infusion of epidermal growth factor in mice: organ distribution and urinary excretion. Regul Pept 1990;29:103-108.
57. Elder JB, Kitt JS, Gregory H. Half-life of urogastrone in conscious dogs. Gut 1978;19:A436.
58. Tyson LM, Browne CA, Jenkin G, Thorburn GD. The fate and uptake of murine epidermal growth factor in the sheep. J Endocrinol 1989;123:121-130.
59. 131I-epidermal growth factor in the pig visualized by dynamic scintigraphy. J Endocrinol 1995;144:5-12.
60. Juhl CO, Vinter-Jensen L, Jensen LS, Nexø E, Djurhuus JC, Dajani EZ. Recombinant human epidermal growth factor accelerates healing of sclerotherapy-induced esophageal ulcers and prevents esophageal stricture formation in pigs. Dig Dis Sci 1994;39:2671-2678.
61. Tsutsumi O, Kurachi H, Oka T. A physiological role of epidermal growth factor in male reproductive function. Science 1986;233:975-977.
62. Liu A, Flores C, Kinkead T, Carboni AA, Menon M, Seethalakshmi L. Effects of sialoadenectomy and epidermal growth factor on testicular function of sexually mature male mice. J Urol 1994;152:554-561.
63. Liu A, Davis RJ, Flores C, Menon M, Seethalakshmi L. Epidermal growth factor: receptor binding and effects on the sex accessory organs of sexually mature male mice. J Urol 1992;148:427-431.
64. Tsutsumi O, Oka T. Epidermal growth factor deficiency during pregnancy causes abortion in mice. Am J Obstet Gynecol 1987;156:241-244.
65. Kamei Y, Tsutsumi O, Kuwabara Y, Taketani Y. Intrauterine growth retardation and fetal losses are caused by epidermal growth factor deficiency in mice. Am J Physiol 1993;264:R597-R600.
66. Tsutsumi O, Taketani Y, Oka T. The uterine growth-promoting action of epidermal growth factor and its function in the fertility of mice. J Endocrinol 1993;138:437-444.
67. Tsutsumi O, Kubota Y, Oka T. Effect of sialoadenectomy, treatment with epidermal growth factor (EGF) antiserum and replacement of EGF on the epidermis in mice. J Endocrinol 1987;113:193-197.
68. Kurachi H, Adachi H, Ohtsuka S, Morishige K-I, Amemiya K, Keno Y, Shimomura I, Tokunaga K, Miyake A, Matsuzawa Y, Tanizawa O. Involvement of epidermal growth factor in inducing obesity in ovariectomized mice. Am J Physiol 1993; 265: E323-E332
69. Adachi H, Kurachi H, Homma H, Adachi K, Imai T, Sakata M, Matsuzawa Y, Miyake A. Involvement of epidermal growth factor in inducing adiposity of aged female mice. J Endocrinol 1995; 146: 381-393
70. Noguchi S, Ohba Y, Oka T. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in mice. J Endocrinol 1991;128:425-431.
71. Smart JL, da Silva VA, Malheiros LR, Paumgartten FJR, Massey RF. Epidermal growth factor advances some aspects of development but retards others in both rats and hamsters. J Dev Physiol 1989;11:153-158.
72. Smith JM, Sporn MB, Roberts AB, Derynck R, Winkler ME, Gregory H. Human transforming growth factor α causes precocious eyelid opening in newborn mice. Nature 1985;315:515-516.
73. Hoath SB. Treatment of the neonatal rat with epidermal growth factor: differences in time and organ response. Pediatr Res 1986;20:468-472.
74. Hoath SB, Pickens WL, Donnelly MM. Epidermal growth factor-induced growth retardation in the new-born rat: quantitation and relation to changes in skin temperature and viscoelasticity. Growth Dev Aging 1988;52:77-83.
75. Donnelly MM, Hoath SB, Pickens WF. Early metabolic consequences of epidermal growth factor administration to neonatal rats. Am J Physiol 1992;263:E920-E927.
76. Chernausek SD, Dickson BA, Smith EP, Hoath SB. Suppression of insulin-like growth factor I during epidermal growth factor-induced growth retardation. Am J Physiol 1991;260;E416-E421.
77. Murray MA, Dickson BA, Smith EP, Hoath SB, Chernausek SD. Epidermal growth factor stimulates insulin-like growth factor-binding-protein-1 expression in the neonatal rat. Endocrinology 1993;133:159-165.
78. Steidler NE, Reade PC. Histomorphological effects of epidermal growth factor on skin and oral mucosa in neonatal mice. Arch Oral Biol 1980;25:37-43.
79. Dembinski AB, Johnson LR. Effect of epidermal growth factor on the development of rat gastric mucosa. Endocrinology 1985;116:90-94.
80. Freund J-N, Duluc I, Foltzer-Jourdainne C, Gosse F, Raul F. Specific expression of lactase in the jejunum and colon during postnatal development and hormone treatments in the rat. Biochem J 1990;268:99-103.
81. Foltzer-Jourdainne C, Raul F. Effect of epidermal growth factor on the expression of digestive hydrolases in the jejunum and colon of newborn rats. Endocrinology 1990;127:1763-1769.
82. Hiramatsu M, Kashimata M, Minami, Minami N, Kumegawa M. Effect of epidermal growth factor on glucosamine-6-phosphate synthetase activity in the colon of neonatal mice. J Endocrinol 1985;105:197-200.
83. Arsenault P, Menard D. Stimulatory effects of epidermal growth factor on deoxyribonucleic acid synthesis in the gastrointestinal tract of the suckling mouse. Comp Biochem Physiol 1987;86B:123-127.
84. Serrero G, Mills D. Physiological role of epidermal growth factor on adipose tissue development in vivo. Proc Natl Acad Sci U S A 1991;88:3912-3916.
85. Read LC, Tarantal A, George-Nascimento C. Effects of recombinant human epidermal growth factor on the intestinal growth of fetal Rhesus monkeys. Acta Paediatr Scand Suppl 1989;351:97-103.
86. Calvert R, Beaulieu J-F, Ménard D. Epidermal growth factor (EGF) accelerates the maturation of fetal mouse intestinal mucosa in utero. Experientia 1982;38:1096-1097.
87. Thorburn GD, Waters MJ, Young IR, Dolling M, Buntine D, Hopkins PS. Epidermal growth factor: a critical factor in fetal maturation. In Dawes GS (ed) The fetus and independent life. (Ciba Foundation Symposium 86), Pitman Ltd. London 1981; 172-198.
88. Sundell HW, Gray ME, Serenius FS, Escobedo MB, Stahlman MT. Effects of epidermal growth factor on lung maturation in fetal lambs. Am J Pathol 1980;100:707-726.
89. Polk DH, Ervin MG, Padbury JF, Lam RW, Reviczky AL, Fisher DA. Epidermal growth factor acts as a corticotropin-releasing factor in chronically catheterized fetal lambs. J Clin Invest 1987;79:984-988.
90. Haigh RM, Hollingsworth M, Micklewright LA, Boyd RDH, D'Souza SW. The effect of human urogastrone on lung phospholipids in fetal rabbits. J Dev Physiol 1988;10:433-443.
91. St.George JA, Read LC, Cranz DL, Tarantal AF, George-Nascimento C, Plopper CG. Effect of epidermal growth factor on the fetal development of the tracheobronchial secretory apparatus in Rhesus monkey. Am J Respir Cell Mol Biol 1991;4:95-101.
92. Plopper CG, St.George JA, Read LC, Nishio SJ, Weir AJ, Edwards L, Tarantal AF, Pinkerton KE, Merritt TA, Whitsett JA, Georg-Nascimento C, Styne D. Acceleration of alveolar type II cell differentiation in fetal rhesus monkey lung by administration of EGF. Am J Physiol 1992;262:L313-L321.
93. Goetzman BW, Read LC, Plopper CG, Tarantal AF, George-Nascimento C, Merritt TA, Whitsett JA, Styne D. Prenatal exposure to epidermal growth factor attenuates respiratory distress syndrome in rhesus infants. Pediatr Res 1994;35:30-36.
94. Raaberg L, Nexø E, Jørgensen PE, Poulsen SS, Jakab M. Fetal effects of epidermal growth factor deficiency induced in rats by autoantibodies against epidermal growth factor. Pediatr Res 1995;37:175-181.
95. Bedrick AD, Ladda RL. Epidermal growth factor potentiates cortisone-induced cleft palate in the mouse. Teratology 1978;17:13-18.
96. Levi-Montalcini R, Cohen S. Effects of the extract of the mouse submaxillary salivary glands on the sympathetic system in mammels. Annals of the New York Academy of Sciences 1960;85:324-341.
97. Moore GPM, Panaretto BA, Carter NB. Epidermal hyperplasia and wool follicle regression in sheep infused with epidermal growth factor. J Invest Dermatol 1985;84:172-175.
98. Panaretto BA, Leish Z, Moore GP, Robertson DM. Inhibition of DNA synthesis in dermal tissue of merino sheep treated with depilatory doses of mouse epidermal growth factor. J Endocrinol 1984;100:25-31.
99. Hollis DE, Chapman RE, Panaretto BA, Moore GP. Morphological changes in the skin and wool fibres of Merino sheep infused with mouse epidermal growth factor. Aust J Biol Sci 1983;36:419-434.
100. Gillespie JM, Marshall RC, Moore GPM, Panaretto BA, Robertson DM. Changes in the proteins of wool following treatment of sheep with epidermal growth factor. J Invest Dermatol 1982;79:197-200.
101. Moore GPM, Panaretto BA, Robertson D. Inhibition of wool growth in merino sheep following administration of mouse epidermal growth factor and a derivative. Aust J Biol Sci 1982;35:163-172.
102. Panaretto BA, Moore GPM, Robertson DM. Plasma concentrations and urinary excretion of mouse epidermal growth factor associated with the inhibition of food consumption and of wool growth in Merino wethers. J Endocrinol 1982;94:191-202.
103. Koffman CG, Elder JB, Ganguli PC, Gregory H, Geary CG. Effect of urogastrone on gastric secretion and serum gastrin concentration in patients with duodenal ulceration. Gut 1982;23:951-956.
104. Elder JB, Gillespie IE, Ganguli PC, Delamore WI, Gregory H. Effect of urogastrone in the Zollinger-Ellison syndrome. Lancet 1975;2:424-427.
105. Guglietta A, Lesch CA, Romano M, McClure RW, Coffey RJ. Effect of transforming growth factor-alpha on gastric acid secretion in rats and monkeys. Dig Dis Sci 1994;39:177-182.
106. Campbell AJ, Adams SS, Davey MW, Titchen DA. Effects of Lys-β-urogastrone in vivo. Aust J Biol Sci 1988;41:463-474.
107. Goodlad RA, Ghatei MA, Domin J, Bloom SR, Gregory H, Wright NA. Plasma enteroglucagon, peptide YY and gastrin in rats deprived of luminal nutrition, and after urogastrone-EGF administration. A proliferative role for PYY in the intestinal epithelium? Experientia 1989;45:168-169.
108. Takayanagi I. Effects of urogastrone on mechanical activities of the stomach and intestine of guinea-pig. J Pharm Pharmacol 1980;32:228-230.
109. McLeay LM, Comeskey MA, Waters MJ. Effects of epidermal growth factor on gastrointestinal electromyographic activity of conscious sheep. J Endocrinol 1990;124:109-115.
110. Fitzpatrick LR, Wang P, Johnson LR. Effect of epidermal growth factor on polyamine-synthesizing enzymes in rat enterocytes. Am J Physiol 1987;252:G209-G214.
111. Scheving LA, Scheving LE, Tsai TH, Vesely DL. Epidermal growth factor enhances guanylate cyclase activity in vivo and in vitro. Endocrinology 1985;116:332-336.
112. Salloum RM, Stevens BR, Schultz GS, Souba WW. Regulation of small intestinal glutamine transport by epidermal growth factor. Surgery 1993;113:552-559.
113. Bird AR, Croom WJ, Fan YK, Daniel LR, Black BL, McBride BW, Eisen EJ, Bull LS, Taylor IL. Jejunal glucose absorption is enhanced by epidermal growth factor in mice. J Nutr 1994;124:231-240.
114. Jacobs DO, Evans DA, Mealy K, O'Dwyer ST, Smith RJ, Wilmore DW. Combined effects of glutamine and epidermal growth factor on the rat intestine. Surgery 1988;104:358-364.
115. Gow CB, Moore GPM. Epidermal growth factor alters milk composition and fluid balance of lactating ewes. J Endocrinol 1992;132:377-385.
116. Gow CB, Wilkinson M, Silvapulle MJ, Moore GPM. Fluid balance, electrolyte profiles and plasma parathyroid hormone concentrations in ewes treated with epidermal growth factor. J Endocrinol 1992;135:91-101.
117. Gow CB, Phillips PA, Chandler KD, Moore GP. Hormonal, fluid, and electrolyte responses of sheep during chronic intravenous infusion of epidermal growth factor. Am J Physiol 1993;265:R203-R210.
118. Gow CB, Phillips PA. Epidermal growth factor as a diuretic in sheep. J Physiol Lond 1994;477:27-33.
119. Phillips PA, Grant SL, Davidson AF, Risvanis J, Stephenson J, Gow CB. Epidermal growth factor antagonizes vasopressin in vivo and in vitro. Kidney Int 1994;45:1028-1036.
120. Harris RC, Hoover RL, Jacobson HR, Badr KF. Evidence for glomerular actions of epidermal growth factor in the rat. J Clin Invest 1988;82:1028-1039.
121. Goodlad RA, Wilson TJG, Lenton W, Gregory H, McCullagh KG, Wright NA. Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats. Gut 1987;28:573-582.
122. Moore GPM, Wilkinson M, Panaretto BA, Delbridge LW, Posen S. Epidermal growth factor causes hypocalcemia in sheep. Endocrinology 1986;118:1525-1529.
123. Scoggins BA, Butkus A, Coghlan JP, Fei DTW, McDougall JG, Niall HD, Walsh JR, Wang X. In vivo cardiovascular, renal and endocrine effects of epidermal growth factor in sheep. Endocrinology 1984;573-576.
124. Sumi S, Inoue K, Hosotani R, Kogire M, Doi R, Yun M, Higashide S, Minote H, Takaori K, Kaji H, Ucidak, Tobe T. Effect of human epidermal growth factor (hEGF) on splanchnic circulation in dogs. Life Sci 1990;47:1115-1119.
125. Carter NB, Fawcett AA, Hales JR, Moore GP, Panaretto BA. Circulatory effects of a depilatory dose of mouse epidermal growth factor in sheep. J Physiol Lond 1988;403:27-39.
126. Gan BS, MacCannell KL, Hollenberg MD. Epidermal growth factor-urogastrone causes vasodilatation in the anesthetized dog. J Clin Invest 1987;80:199-206.
127. Corcoran JM, Waters MJ, Eastman CJ, Jorgensen G. Epidermal growth factor: effect on circulating thyroid hormone levels in sheep. Endocrinology 1986;119:214-217.
128. Ahren B. Epidermal growth factor (EGF) inhibits stimulated thyroid hormone secretion in the mouse. Peptides 1987;8:743-745.
129. Singh-Asa P, Waters MJ. Stimulation of adrenal cortisol biosynthesis by epidermal growth factor. Mol Cell Endocrinol 1983;30:189-199.
130. Shaw G, Jorgensen GI, Tweedale R, Tennison M, Waters MJ. Effect of epidermal growth factor on reproductive function of ewes. J Endocrinol 1985;107:429-436.
131. Murray JF, Downing JA, Evans G, Findlay JK, Scaramuzzi RJ. Epidermal growth factor acts directly on the sheep ovary in vivo to inhibit oestradiol-17 beta and inhibin secretion and enhance progesterone secretion. J Endocrinol 1993;137:253-264.
132. Radford HM, Panaretto BA, Avenell JA, Turnbull KE. Effect of mouse epidermal growth factor on plasma concentrations of FSH, LH and progesterone and on oestrus, ovulation and ovulation rate in merino ewes. J Reprod Fertil 1987;80:383-393.
133. Moore GPM, Panaretto BA, Wallace AL. Treatment of ewes at different stages of pregnancy with epidermal growth factor: effects on wool growth and plasma concentrations of growth hormone, prolactin, placental lactogen and thyroxine and on foetal development. Acta Endocrinol Copenh 1984;105:558-566.
134. Juhl CO, Jensen LS, Steiniche T, Moussa E. Recombinant human epidermal growth factor prevents sclerotherapy-induced esophageal ulcer and stricture formations in pigs. Dig Dis Sci 1994;32:393-401.
135. Vinter-Jensen L, Juhl CO, Eika B, Gregersen H, Dajani EZ. Epidermal growth factor attenuates the sclerotherapy-induced biomechanical properties of the oesophagus. An experimental study in minipigs. Scand J Gastroenterol 1995;30:614-619.
136. Juhl CO, Vinter-Jensen L, Jensen LS, Dajani EZ. Preventive effects of recombinant human epidermal growth factor on the oesophageal epithelium in pigs subjected to sclerotherapy. Eur J Hepatol Gastroenterol 1995;7:823-828.
137. Amagase H, Murakami T, Misaki M, Higashi Y, Ushijima M, Fuwa T, Yata N. Protective effect of human epidermal growth factor against the experimental gastric mucosal lesions in rats. Life Sci 1990;47:1031-1036.
138. Konturek SJ, Dembinski A, Warzecha Z, Brzozowski T, Gregory H. Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 1988;94:1300-1307.
139. Romano M, Polk WH, Awad JA, Arteaga CL, Nanney LB, Wargovich MJ, Kraus ER, Boland ER, Coffey RJ. Transforming growth factor α protection against drug-induced injury to the rat gastric mucosa in vivo. J Clin Invest 1992;90:2409-2421.
140. Thompson JS, Saxena SK, Sharp JG. Effect of urogastrone on intestinal regeneration is dose-dependent. Cell Tissue Kinet 1988;21:183-191.
141. Thompson JS, Saxena SK, Greaton C, Schultz G, Sharp JG. The effect of the route of delivery of urogastrone on intestinal regeneration. Surgery 1989;106:45-51.
142. Thompson JS, Saxena SK, Sharp JG. Difluoromethylornithine inhibits urogastrone stimulation of neomucosal growth. J Surg Res 1988;44:589-595.
143. Thompson JS, Nguyen B-LT, Harty RF. Somatostatin analogue inhibits intestinal regeneration. Arch Surg 1993;128:385-389.
144. Swaniker F, Guo W, Fonkalsrud EW, Diamond J. The effect of epidermal growth factor on mucosal function after ileal resection. J Surg Res 1995;58:565-569.
145. Kingsnorth AN, Vowles R, Nash JRG. Epidermal growth factor increases tensile strength in intestinal wounds in pigs. Br J Surg 1990;77:409-412.
146. Luck MS, Bass P. Effect of epidermal growth factor on experimental colitis in the rat. J Pharmacol Exp Ther 1993;264:984-990.
147. Procaccino F, Reinshagen M, Hoffmann P, Zeeh JM, Lakshmanan J, McRoberts JA, Patel A, French S, Eysselein VE. Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology 1994;107:12-17.
148. Goodlad RA, Lee CY, Wright NA. Cell proliferation in the small intestine and colon of intravenously fed rats: effects of urogastrone-epidermal growth factor. Cell Prolif 1992;25:393-404.
149. Bragg LE, Hollingsed TC, Thompson JS. Urogastrone reduces gut atrophy during parenteral alimentation. J Parenter Enteral Nutr 1990;14:283-286.
150. Foster HM, Whitehead RH. Intravenous but not intracolonic epidermal growth factor maintains colonocyte proliferation in defunctioned rat colorectum. Gastroenterology 1990;99:1710-1714.
151. Walker Smith JA, Phillips AD, Walford N, Gregory H, Fitzgerald JD, MacCullagh K, Wright NA. Intravenous epidermal growth factor/urogastrone increases small-intestinal cell proliferation in congenital microvillous atrophy. Lancet 1985;2:1239-1240.
152. Drumm B, Cutz E, Tomkins KB, Cook D, Hamilton JR, Sherman P. Urogastrone/epidermal growth factor in treatment of congenital microvillous atrophy. Lancet 1988;1:111-112.
153. Sullivan PB, Brueton MJ, Tabara ZB, Goodlad RA, Lee CY, Wright NA. Epidermal growth factor in necrotising enteritis. Lancet 1991;338:53-54.
154. Matsuo Y, Gotoh Y, Itoh M. Randomized double-blind comparison of epidermal growth factor from human urine (MG111) with the active placebo in treatment of gastric ulcer. First United European Gastroenterology Week,Athens 1992;Abstract.
155. Humes HD, Cieslinski DA, Coimbra TM, Messana JM, Galvao C. Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 1989;84:1757-1761.
156. Norman J, Tsau Y-K, Bacay A, Fine LG. Epidermal growth factor accelerates functional recovery from ischaemic acute tubular necrosis in the rat: role of the epidermal growth factor receptor. Clin Sci 1990;78:445-450.
157. Coimbra TM, Cieslinski DA, Humes HD. Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. Am J Physiol 1990;259:F438-F443.
158. Morin NJ, Laurent G, Nonclercq D, Toubeau G, Heuson Stiennon J-A, Bergeron MG, Beauchamp D. Epidermal growth factor accelerates renal tissue repair in a model of gentamicin nephrotoxicity in rats. Am J Physiol 1992;263:F806-F811.
159. Rasmussen TN, Jørgensen PE, Almdal T, Kirkegaard P, Olsen PS. Stimulatory effect of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Scand J Gastroenterol 1992;27:372-374.
160. Kokudo N, Kothary PC, Eckhauser FE, Raper SE. Transforming growth factor-α (TGF-α) improves hepatic DNA synthesis after hepatectomy in cirrhotic rats. J Surg Res 1992;52:648-655.
161. Webber EM, Godowski PJ, Fausto N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 1994;14:489-497.
162. Barrow RE, Wang CZ, Evans MJ, Herndon DN. Growth factors accelerate epithelial repair in sheep trachea. Lung 1993;171:335-344.
163. Laato M. Effect of epidermal growth factor (EGF) on blood flow and albumin extravasation in experimental granulation tissue. Acta Chir Scand 1986;152:401-405.
164. Celebi N, Erden N, Gönül B, Koz M. Effects of epidermal growth factor dosage forms on dermal wound strength in mice. J Pharm Pharmacol 1994;46:386-387.
165. Nanney LB. Epidermal and dermal effects of epidermal growth factor during wound repair. J Invest Dermatol 1990;94:624-629.
166. Rich LF, Hatfield JM, Louiselle I. The influence of epidermal growth factor on cat corneal endothelial wound healing. Curr Eye Res 1991;10:823-830.
167. Beaubien J, Boisjoly HM, Gagnon P, Guidoin R. Mechanical properties of the rabbit cornea during wound healing after treatment with epidermal growth factor. Can J Ophthalmol 1994;29:61-65.
168. Pastor JC, Calonge M. Epidermal growth factor and corneal wound healing. A multicenter study. Cornea 1992;11:311-314.
169. Franklin JD, Lynch JB. Effects of topical applications of epidermal growth factor on wound healing. Experimental study on rabbit ears. Plast Reconstr Surg 1979;64:766-770.
170. O'Daniel TG, Petitjean M, Jones SC, Zogg J, Martinez SA, Nolph MB, Schultz GS. Epidermal growth factor binding and action on tympanic membranes. Ann Otol Rhinol Laryngol 1990;99:80-84.
171. Kirkegaard P, Olsen PS, Poulsen SS, Nexø E. Epidermal growth factor inhibits cysteamine-induced duodenal ulcers. Gastroenterology 1983;85:1277-1283.
172. Olsen PS, Poulsen SS, Kirkegaard P, Nexø E. Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology 1984;87:103-108.
173. Olsen PS, Poulsen SS, Therkelsen K, Nexø E. Effect of sialoadenectomy and synthetic human urogastrone on healing of chronic gastric ulcers in rats. Gut 1986;27:1443-1449.
174. Skov Olsen P, Poulsen SS, Therkelsen K, Nexø E. Oral administration of synthetic human urogastrone promotes healing of chronic duodenal ulcers in rats. Gastroenterology 1986;90:911-917.
175. Vinter-Jensen L, Smerup M, Jørgensen PE, Juhl CO, Ørntoft T, Poulsen SS, Nexø E. Chronic treatment in the rat with epidermal growth factor stimulates growth of the urinary tract. Urol Res 1996;24:15-21.
176. Vinter-Jensen L, Flyvbjerg A, Nexø E. Systemic treatment with EGF
177. Breider MA, Bleavins MR, Reindel JF, Gough AW, de la Iglesia FA. Cellular hyperplasia in rats following continuous intravenous infusion of recombinant human epidermal growth factor. Vet Pathol 1996;33:184-194.
178. Maraschin R, Bussi R, Gonz A, Orlando L, Pirovano R, Nyska A. Toxicological evaluation of u-hEGF. Toxicologic Pathology 1995;23:356-366.
179. Vinter-Jensen L, Juhl CO, Poulsen SS, Djurhuus JC, Dajani EZ, Nexø E. Chronic administration of epidermal growth factor to pigs induces growth especially of the urinary tract with accumulation of epithelial glycoconjugates. Lab Invest 1995;73:788-793.
180. Frystyk J, Vinter-Jensen L, Skjærbæk C, Flyvbjerg A. The effect of epidermal growth factor on circulating levels of free and total IGF-I and TGF-binding proteins in adult rats. Growth Regul 1996;6:48-54.
181. Berseth CL, Go VLW. Enhancement of neonatal somatic and hepatic growth by orally administered epidermal growth factor in rats. J Pediatr Gastroenterol Nutr 1988;7:889-893.
182. Vinter-Jensen L, Juhl CO, Dajani EZ, Nielsen K, Djurhuus JC. Chronic systemic treatment with epidermal growth factor induces smooth muscle cell hyperplasia and hypertrophia in the urinary tract of mature Goettingen minipigs. Br J Urol 1997; 79: 532-538.
183. Vinter-Jensen L, Juhl CO, Djurhuus JC, Poulsen SS, Dajani EZ, Brown KD, Ørntoft TF, Teglbjærg PS, Nexø E. Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates. Am J Pathol 1995;147:1330-1338.
184. Vinter-Jensen L, Nielsen K. The effects of exogenous epidermal growth factor on the developing urinary tract in rats: a stereological description. Urol Res 1998;26:105-110.
185. Vinter-Jensen L, Ørntoft TF. Glycoproteins in the urothelium and in the urine of the epidermal growth factor induced growing urinary tract in rats. Urol Res 1998;26:97-103.
186. Vinter-Jensen L, Uvelius B, Nexø E, Arner A. Contractile and cytoskeletal proteins in bladder smooth muscle from rats treated with epidermal growth factor. Urol Res 1996;24:229-234.
187. Vinter-Jensen L, Kirik D, Arner A, Nexø E, Uvelius B. Acute contractile effects of epidermal growth factor (EGF) on bladder smooth muscles. An in vivo and in vitro study in rats. Scand J Urol Nephrol 1997;31:231-235.
188. Rall LB, Scott J, Bell GI, Crawford RJ, Penschow JD, Niall HD, Coghlan JP. Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature 1985;313:228-231.
189. Skov Olsen P, Nexø E, Poulsen SS, Hansen HF, Kirkegaard P. Renal origin of rat urinary epidermal growth factor. Regul Pept 1984;10:37-45.
190. Jørgensen PE, Hilchey SD, Nexø E, Poulsen SS, Quilley CP. Urinary epidermal growth factor is excreted from the rat isolated perfused kidney in the absence of plasma. J Endocrinol 1993;139:227-234.
191. Cilento BG, Freeman MR, Schneck FX, Retik AB, Atala A. Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. J Urol 1994;152:665-670.
192. Baskin LS, Surtherland S, Thompson AA, Hayward SW, Cunha GR. Growth factors and receptors in bladder development and obstruction. Lab Invest 1996;75:157-166.
193. De Boer WI, Vermeij M, Gil Diez de Medina S, Bindels E, Radvanyi F, van der Kwast T, Chopin D. Functions of fibroblast and transforming growth factors in primary organoid-like cultures of normal human urothelium. Lab Invest 1996;75:147-156.
194. Messing EM, Hanson P, Ulrich P, Erturk E. Epidermal growth factor - interactions with normal and malignant urothelium: in vivo and in situ studies. J Urol 1987;138:1329-1335.
195. Noguchi S, Yura Y, Sherwood ER, Kakinuma H, Kashihara N, Oyasu R. Stimulation of stromal cell growth by normal rat urothelial cell-derived epidermal growth factor. Lab Invest 1990;62:538-544.
196. Remy L. The intracellular lumen: origin, role and implications of a cytoplasmic neostructure. Int Biol Cell 1986;56:97-106.
197. Quincey C, Raitt N, Bell J, Ellis IO. Intracytoplasmic lumina - a useful diagnostic feature of adenocarcinomas. Histopathology 1991;19:83-87.
198. Sobrinho-Simoes M, Johannesen JV, Gould VE. The diagnostic significance of intracytoplasmic lumina in metastatic neoplasms. Ultrastructural Pathology 1981;2:327-335.
199. Alroy J, Pauli BU, Hayden JE, Gould VE. Intracytoplasmic lumina in bladder carcinomas. Human Pathology 1979;10:549-555.
200. Limas L, Lange P. T-antigen in normal and neoplastic urothelium. Cancer 1986;58:1236-1245.
201. Nishiyama T, Matsumoto Y, Watanabe H, Fujiwara M, Sato S. Detection of Tn antigen with vicia villosa agglutinin in urinary bladder cancer: Its relevance to the patients clinical course. JNCI 1987;78:1113-1118.
202. Langkilde NC, Hastrup J, Olsen S, Wolf H, Ørntoft TF. Immunohistochemistry and cytochemistry of experimental rat bladder cancer: binding of the lectins PNA and WGA and of a Ley mouse monoclonal antibody. J Urol 1989;141:981-986.
203. Langkilde, N.C. Studies on the expression of T(Galβ (1-3)GalNacl-O-R and T-like antigens in experimental rat bladder cancer. Doctoral Thesis. Aarhus University 1996.
204. Mandel U. Carbohydrates in oral epithelia and secretions: Variation with cellular differentiation. APMIS 1992;100 suppl 27:119-129.
205. Juhl CO, Vinter-Jensen L, Poulsen SS, Ørntoft TF, Dajani EZ. Chronic treatment with epidermal growth factor causes esophageal epithelial hyperplasia in pigs and rats. Dig Dis Sci 1995;40:2717-2723.
206. Lomberg H, Cedergren B, Leffler H, Nilsson B, Carlstrøm AS, Svandborg-Eden C. Influence of blood group on the availability of receptors for attachment of uropathogenic Escherichia coli. Infect Immun 1985;51:919-923
207. Svandborg Eden C, Freter R, Hagberg L, Hull R, Hull S, Leffler H, Schoolnik G. Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature 1982;298:560-562.
208. Bock K, Breimer ME, Brignole A, Hansson GC, Karlsson K-A, Larson G, Leffler H, Samuelsson BE, Strömberg N, Svanborg Eden S, Thurin J. Specificity of binding of a strain of uropathogenic Escherichia coli to Galα1-4Gal-containing glycosphingolipids. J Biol Chem 1985;260:8545-8551.
209. Hurst RE. Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract. World J Urol 1994;12:3-10.
210. Parsons CL, Mulholland SG. Bladder surface mucin. Am J Pathol 1978;93:423-432.
211. Gill WB, Ruggioro K, Strauss H. Crystallization studies in a urothelial-lined living test tube (the catheterized female rat bladder). Invest Urol 1979;17:257-261.
212. Neal DE, Mellon K. Epidermal growth factor receptor and bladder cancer: a review. Urol Int 1992;48:365-371.
213. Sauter G, Haley J, Chew K, Kerschmann R, Moore D, Carroll P, Moch H, Gudat F, Mihatsch MJ, Waldman F. Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer 1994;57:508-514.
214. Wright C, Mellon K, Johnston P, Lane DP, Harris AL, Horne CHW, Neal DE. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 1991;63:967-970.
215. Kawai K, Kawamata H, Kameyama S, Rademaker A, Oyasu R. Intraluminal epidermal growth factor affects growth of N-methyl-N-nitrosourea-initiated rat bladder carcinoma. J pn J Cancer Res 1995;86:429-434.
216. Momose H, Kakinuma H, Shariff SY, Mitchell GB, Rademaker A, Oyasu R. Tumor-promoting effect of urinary epidermal growth factor in rat urinary bladder carcinogenesis. Cancer Res 1991;51:5487-5490.
217. Inui M, Nishi N, Yasamoto A, Takenaka I, Miyanaka H, Matsumoto K, Nakamura T, Wada F. Enhanced gene expression of transforming growth factor and c-met in rat urianry bladder cancer. Urol Res 1996;24:55-60.
218. Kawamata H, Kameyama S, Oyasu R. In vitro and in vivo acceleration of the neoplastic phenotype of a low-tumorigenicity rat bladder carcinoma cell line by transfected transforming growth factor-alpha. Mol Carcinogenesis 1994;9:210-219.
219. De Boer WI, Rebel JM, Thijssen CDEM, Vermeij M, van den Eijnden AJM, van Raaij AJ, van der Kwast TH. Hyperplasia of epithelium adjacent to transitional cell carcinoma can be induced by growth factors through paracrine pathways. Virchows Arch 1994;425:439-444.
220. Cohen SM, Garland EM, Gano M, St John MK, Khachab M, Wehner JM, Arnold LL. Effects of sodium ascorbate, sodium saccharin and ammonium chloride on the male urinary bladder. Carcinogenesis 1995;16:2743-2750.
221. Garland EM, Sakata T, Fischer MJ, Masui T, Cohen SM. Influences of diet and strain on the proliferative effect on the rat urinary bladder induced by sodium saccharin. Cancer Research 1989;49:3789-3794.
222. Molley CJ, Laskin JD. Effect of retinoid deficiency on keratin expression in mouse bladder. Exp Mol Pathol 1988;49:3789-3794.
223. Radomski JL, Glass EM, Deichman WB. Transitional cell hyperplasia in the bladders of dogs fed DL-tryptophan. Cancer Res 1971; 31:1690-1694.
224. Ertürk E, Price JM, Morris JE, Cohen S, Leith RS, Von-Esch AM, Crovetti AJ. The production of carcinoma of the urinary bladder in rats by feeding N-(3-(5-nitro-2-furyl)-thiazolyl)formamide. Cancer Res 1967;27:1998-2002.
225. Brent L, Stephens FD. The response of smooth muscle cells in the rabbit urinary bladder to outflow obstuction. Invest Urol 1975;12:494-502.
226. Mayo ME, Hinman F. Structure and function of the rabbit bladder altered by chronic obstruction or cystitis. Invest Urol 1976;14:6-9.
227. Uvelius B, Persson L, Mattiasson A. Smooth muscle cell hypertrophy and hyperplasia in the rat detrusor after short-time infravesical outflow obstruction. J Urol 1984;131:173-176.
228. Nielsen KK, Andersen CB, Petersen LK, Oxlund H, Nordling J. Morphological, stereological, and biochemical analysis of the mini-pig urinary bladder after chronic outflow obstruction and after recovery from obstruction. Neurourol Urodyn 1995;14:269-284.
229. Meyer S, Elbadawi A. Morphometry of the obstructed detrusor: II. Principles of a comprehensive protocol. Neurourol Urodyn 1989;8:173-191.
230. Karim OMA, Seki N, Mostwin JL. Detrusor hyperplasia and expression of "immediately early" genes with onset of abnormal urodynamic parameters. Am J Physiol 1992;263:R1284-R1290.
231. Karim OMA, Pienta K, Seki N, Mostwin JL. Stretch-mediated visceral smooth muscle growth in vitro. Am J Physiol 1992;262:R895-R900.
232. Tammela TLJ, Longhurst PA, Wein AJ, Levin RM. The effect of furosemide-induced diuresis on rabbit micturition and bladder contractile function. J Urol 1993;150:204-208.
233. Monson FC, McKenna BAW, Wein AJ, Levin RM. Effect of outlet obstruction on 3H-thymidine uptake: a biochemical and radioautographic study. J Urol 1991;148:158-162.
234. Vinter-Jensen L, Juhl CO, Stubbe Teglbjærg P, Poulsen SS, Dajani EZ, Nexø E. Systemic treatment with epidermal growth factor induces ductal proliferations in the pancreas. Gastroenterology 1997; 113:1367-1374.
235. Itzkowitz S, Kjeldsen T, Friera A, Hakomori S-I, Yang U-S, Kim YS. Expresssion of Tn, Sialosyl Tn and T antigens in human pancreas. Gastroenterology 1991;100:1691-1700.
236. Lack EE. Primary tumors of the exocrine pancreas. Am J Surg Pathol 1989;13(suppl):66-88.
237. Sessa F, Bonato M, Frigerio B, Capella C, Solcia E, Prat M, Bara J, Samloff IM. Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells. Gastroenterology 1990;98:1655-1665.
238. Xerri L, Payan M, Choux R, Gros N, Figarella-Branger D, Sarles H. Predominance of sialomucin secretion in malignant and premalignant pancreatic lesions. Hum Pathol 1990;21:927-931.
239. Pour PM. Mechanism of pseudoductular (tubular) formation during pancreatic carcinogenesis in the hamster model. An electron-microscopic and immunohistochemical study. Am J Pathol 1988;130:335-344.
240. Pour PM, Runge RG, Birt D, Gingell R, Lawson T, Nagel D, Wallcave L, Shahrokh ZS. Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to human disease. Cancer 1981;47:1573-1587.
241. Shephard JG, Chen JR, Tsao M-S, Duguid WP. Neoplastic transformation of propagable cultured rat pancreatic duct epithelial cells by azaserine and streptozotocin. Carcinogencsis 1993;14:1027-1033.
242. Albores-Saavedra J, Nadji M, Henson DE, Angeles-Angeles A. Entero-endocrine cell differentiation in carcinomas of the gallbladder and mucinous cystadenocarcinomas of the pancreas. Path Res Pract 1988;183:169-175.
243. Korc M. Islet growth factors: curing diabetes and preventing chronic pancreatitis? J Clin Invest 1993;92:1113-1114.
244. Wang TC, Bonner-Weir S, Oates PS, Chulak M, Simon B, Merlino GT, Schmidt EV, Brand SJ. Pancreatic gastrin stimulates islet differentiation of transforming growth factor α-induced ductular precursor cells. J Clin Invest 1993;92:1349-1356.
245. Vinter-Jensen L, Juhl CO, Rehfeld JF, Poulsen SS, Dajani EZ, Nexø E. Chronic systemic treatment with epidermal growth factor induces hypergastrinaemia in Goettingen Minipigs. Scand J Gastroenterol 1995;30:422-427.
246. Bachwich D, Merchant J, Brand SJ. Identification of a cis-regulatory element mediating somatostatin inhibition of epidermal growth factor-stimulated gastrin gene transcription. Mol Endocrinol 1992;6:1175-1184.
247. Korc M, Friess H, Yamanaka Y, Kobrin MS, Buchler M, Beger HG. Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor α, and phospholipase Cγ. Gut 1994;35:1468-1473.
248. Barton CM, Hall PA, Hughes CM, Gullick WJ, Lemoine NR. Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol 1991;163:111-116.
249. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Buchier M, Beger HG. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 1992;90:1352-1360.
250. Yamanaka Y, Friess H, Kobrin MS, Buchler M, Beger HG, Korc M. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res 1993;13:565-569.
251. Ebert M, Yokoyama M, Kobrin MS, Friess H, Lopez ME, Büchler MW, Johnson GR, Korc M. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res 1994;54:3959-3962.
252. Friess H, Yamanaka Y, Buchler M, Kobrin MS, Tahara E, Korc M. Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis. Int J Cancer 1994;56:668-674.
253. Hall PA, Hughes CM, Staddon SL, Richman PI, Gullick WJ, Lemoine NR.The c-erbB-2 proto-oncogene in human pancreatic cancer. J Pathol 1990;161:195-200.
254. Lemoine NR, Lobresco M, Leung H, Barton C, Hughes CM, Prigent SA, Gullick WJ, Klöppel G. The erbB-3 gene in human pancreatic cancer. J Pathol 1992;168:269-273.
255. de Juan C, Benito M, Fabregat I. Regulation of albumin expression in fetal rat hepatocytes cultured under proliferative conditions: role of epidermal growth factor and hormones. J Cell Physiol 1992;152:95-101.
256. Bosch F, Bouscarel B, Slaton J, Blackmore PF, Exton JH. Epidermal growth factor mimics insulin effects in rat hepatocytes. Biochem J 1986;239:523-530.
257. Soler C, Poveda B, Soley M, Pastor Anglada M. Effect of epidermal growth factor on ornithine decarboxylase activity and urea synthesis in isolated rat hepatocytes. Cell Mol Biol 1992;38:281-288.
258. Jaeger LA, Lamar CH. Immunolocalization of epidermal growth factor (EGF) and EGF receptors in the porcine upper gastrointestinal tract. Am J Vet Res 1992;53:1685-1692.
259. Sarosiek J, Feng T, McCallum RW. The interrelationship between salivary epidermal growth factor and the functional integrity of the esophageal mucosal barrier in the rat. Am J Med Sci 1991;302:359-363.
260. Sarosiek J, Bilski J, Murty VL, Slomiany A, Slomiany BL. Role of salivary epidermal growth factor in the maintenance of physicochemical characteristics of oral and gastric mucosal mucus coat. Biochem Biophys Res Commun 1988;152:1421-1427.
261. Jankowski J, Hopwood D, Wormsley KG. Expression of epidermal growth factor, transforming growth factor alpha and their receptor in gastro-oesophageal diseases. Dig Dis 1993;11:1-11.
262. Itakura Y, Sasano H, Shiga C, Furukawa Y, Shiga K, Mori S, Nagura H. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Cancer 1994;74:795-804.
263. Yoshida K, Kuniyasu H, Yasui W, Kitadai Y, Toge T, Tahara E. Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha. J Cancer Res Clin Oncol 1993;119:401-407.
264. Yoshida Y, Okamura T, Shirakusa T. An immunohistochemical study of helix pomatia agglutinin binding on carcinomas of the esophagus. Surg-Gynecol-Obstet 1993;177:299-302.
265. Tepperman BL, Soper BD. Effect of sialoadenectomy on gastric mucosal integrity and growth in the rat. A time-course study. Dig Dis Sci 1990;35:943-949.
266. Mori S, Morishita Y, Sakai K, Kurimoto S, Okamoto M, Kawamoto T, Kuroki T. Electron microscopic evidence for epidermal growth factor receptor (EGF-R)-like immunoreactivity associated with the basolateral surface of gastric parietal cells. Acta Pathol Jpn 1987;37:1909-1917.
267. Orsini B, Calabró A, Milani S, Grappone C, Herbst H, Surrenti C. Localization of epidermal growth factor/ transforming growth factor-α receptor in the human gastric mucosa. An immunohistochemical and in situ hybridization study. Virchows Arch A Pathol Anat 1993;423:57-63.
268. Gedde-Dahl D. Relation between gastrin response to food stimulation and pentagastrin stimulated gastric acid secretion in normal humans. Scand J Gastroenterol 1974;9:447-450.
269. Brand SJ, Stone D. Reciprocal regulation of antral gastrin and somatostatin gene expression by omeprazole-induced achlorhydria. J Clin Invest 1988;82:1059-1066.
270. Vinter-Jensen L, Smerup M, Kissmeyer-Nielsen P, Poulsen SS. Chronic systemic treatment with epidermal growth factor in the rat increases the mucosal surface of the small intestine. Regul Pept 1995;60:117-124.
271. Kissmeyer-Nielsen P, Vinter-Jensen L, Smerup M. Effects of longterm epidermal growth factor treatment on the normal rat colon. Gut 1996;38:582-586.
272. Scheving LA, Shiurba RA, Nguyen TD, Gray GM. Epidermal growth factor receptor of the intestinal enterocyte. Localization to laterobasal but not brush border membrane. J Biol Chem 1989;264:1735-1741.
273. Thompson JF, Van Den Berg M, Stokkers PCF. Developmental regulation of epidermal growth factor receptor kinase in rat intestine. Gastroenterology 1994;107:1278-1287.
274. Opleta-Madsen K, Hardin J, Gall DG. Epidermal growth factor upregulates intestinal electrolyte and nutrient transport. Am J Physiol 1991;260:G807-G814.
275. Hardin JA, Buret A, Meddings JB, Gall DG. Effect of epidermal growth factor on enterocyte brush-border surface area. Am J Physiol 1993;264:G312-G318.
276. Juhl CO, Vinter-Jensen L, Myhre-Jensen O, Jensen LS, Dajani EZ. Systemic treatment with epidermal growth factor induces anaemia in Goettingen minipigs. Clin Sci 1995;89:453-458.
277. Engelmann B, Schumacher U, Haen E. Epidermal growth factor binding sites on human erythrocytes in donors with different ABO blood groups. Am J Hematol 1992;39:239-241.
278. Brach MA, Sott C, Kiehntopf M, Herrmann F. Expression of the transforming growth factor-a gene by human eosinophils is regulated by interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor. Eur J Immunol 1994;24:646-650.
279. Pain B, Woods CM, Saez J, Flickinger T, Raines M, Peyrol S, Moscovici C, Moscovici MG, Kung H-J, Jurdic P Lazarides E, Samarut J. EGF-R as a hemopoietic growth factor receptor: the c-erbB product is present in chicken erythrocytic progenitors and controls their self-renewal. Cell 1991;65:37-46.
280. Hayman MJ, Meyer S, Martin F, Steinlein P, Beug H. Self-renewal and differentiation of normal avian erythroid progenitor cells: regulatory roles of the TGFα/c-ErbB and SCF/c-kit receptors. Cell 1993;74:157-169.
281. Yeh YC, Scheving LA, Tsai TH, Scheving LE. Circadian stage-dependent effects of epidermal growth factor on deoxyribonucleic acid synthesis in ten different organs of the adult male mouse. Endocrinology 1981;109:644-651.
282. Vinter-Jensen L, Jørgensen PE, Poulsen SS, Nexø E. The effects of chronic administration of epidermal growth factor (EGF) to rats on the levels of endogenous EGF in the submandibular glands and kidneys. Regul Pept 1996;67:179-185.
283. Killion D, Canfield G, Normal J, Rosenthal JT. Exogenous epidermal growth factor fails to accelerate functional recovery in the autotransplanted ischemic pig kidney. J Urol 1993;150:1551-1556.
284. Vehaskari VM, Hering-Smith KS, Moskowitz DW, Weiner ID, Hamm LL. Effect of epidermal growth factor on sodium transport in the cortical collecting tubule. Am J Physiol 1989;256:F803-F809.
285. Sack E, Talor Z. High affinity binding sites for epidermal growth factor (EGF) in renal membranes. Biochem Biophys Res Commun 1988;154:312-317.
286. Harris RC, Daniel TO. Epidermal growth factor binding, stimulation of phosphorylation, and inhibition of gluconeogenesis in rat proximal tubule. J Cell Physiol 1989;139:383-391.
287. Harris RC. Response of rat inner medullary collecting duct to epidermal growth factor. Am J Physiol 1989;256:F1117-F1124.
288. Behrens MT, Corbin AL, Hise MK. Epidermal growth factor receptor regulation in rat kidney: two models of renal growth. Am J Physiol 1989;257:F1059-F1064.
289. Breyer MD, Jacobson HR, Breyer JA. Epidermal growth factor inhibits the hydroosmotic effect of vasopressin in the isolated perfused rabbit cortical collecting tubule. J Clin Invest 1988;82:1313-1320.
290. Norman J, Badie Dezfooly B, Nord EP, Kurtz I, Schlosser J, Chaudhari A, Fine LG. EGF-induced mitogenesis in proximal tubular cells: potentiation by angiotensin II. Am J Physiol 1987;253:F299-F309.
291. Jones JI, Clemmons DR. Insulin-Like Growth Factors and their binding proteins: Biological actions. Endocr Rev 1995;16:3-34.
292. Thissen J-P, Ketclsleger J-M, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994;15:80-101.
293. Froesch ER, Guler H-P, Schmid C, Binz K, Zapf J. Therapeutic potential of insulin-like growth factor I. TEM 1990;1:254-260.
294. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross JJ. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 1995;95:619-627.
295. Vinter-Jensen L, Juhl CO, Frystyk J, Dajani EZ, Oksbjerg N, Flyvbjerg A. The effect of epidermal growth factor on circulating levels of IGF and IGF-binding proteins in adult Goettingen minipigs. J Endocrinol 1996;151:401-407.
296. Tørring N, Vinter-Jensen L, Pedersen SB, Sorensen FB, Flyvbjerg A, Nexø E. Systemic administration of insulin-like growth factor I (IGF-I) causes growth of the rat prostate. J Urol 1997;158:222-227.
297. Dai J, Scott CD, Baxter RC. Regulation of the acid-labile subunit of the insulin-like growth factor complex in cultured rat hepatocytes. Endocrinology 1994;135:1066-1072.
298. Barreca A, Voci A, Minuto F, de Marchis M, Cecchelli E, Fugassa E, Giordano G, Gallo G. Effect of epidermal growth factor on insulin-like growth factor-I (IGF-I) and IGF-binding protein synthesis by adult rat hepatocytes. Mol Cell Endocrinol 1992;84:119-126.
299. Pascall JC, Jones DSC, Doel SM, Clements JM, Hunter M, Fallon T, Edwards M, Brown KD. Cloning and characterization of a gene encoding pig epidermal growth factor. J Mol Endocrinol 1991;6:63-70.
300. Opleta Madsen K, Meddings JB, Gall DG. Epidermal growth factor and postnatal development of intestinal transport and membrane structure. Pediatr Res 1991;30:342-350.
301. Opleta K, O'Loughlin EV, Shaffer EA, Hayden J, Hollenberg M, Gall DG. Effect of epidermal growth factor on growth and postnatal development of the rabbit liver. Am J Physiol 1987;253:G622-G626.
302. Coles HSR, Burne JF, Raff MC. Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 1993;118:777-784.
303. Goodlad RA, Gregory H, Wright NA. Is polyamine synthesis involved in the proliferative response of the intestinal epithelium to urogastrone-epidermal growth factor? Clin Sci 1989;76:595-598.
304. Goodlad RA, Savage AP, Lenton W, Ghatei MA, Gregory H, Bloom SR, Wright NA. Does resection enhance the response of the intestine to urogastrone-epidermal growth factor in the rat? Clin Sci 1988;75:121-126.
305. Thompson JS, Saxena SK, Sharp JG. Effect of the duration of infusion of urogastrone on intestinal regeneration in rabbits. Cell Tissue Kinet 1989;22:303-309.
306. McKenna KJ, Ligato S, Kauffman GLJ, Abt AB, Stryker JA, Conter RL. Epidermal growth factor enhances intestinal mitotic activity and DNA content after acute abdominal radiation. Surgery 1994;115:626-632.
307. Robinson BA, Clutterbuck RD, Millar JL, McElwain TJ. Epidermal growth factor (hEGF) has no effect on murine intestine epithelial damage and regeneration after melphalan. Br J Cancer 1985;52:733-737.
308. Zapata-Sirvent RL, Hansbrough JF, Wolf P, Grayson LS, Nicolson M. Epidermal growth factor limits structural alterations in gastrointestinal tissues and decreases bacterial translocation in burned mice. Surgery 1993;113:564-573.
309. Skov Olsen P, Boesby S, Kirkegaard P, Therkelsen K, Almdal T, Poulsen SS, Nexø E. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology 1988;8:992-996.
310. Christiansen JJ, Vinter-Jensen L, Nielsen K. Systemic treatment in the rat with epidermal growth factor causes polycystic growth of the ovaries. APMIS 1996;104:147-152.
311. Vinter-Jensen L. Pharmacokinetics and systemic effects of epidermal growth factor (EGF) in pigs. Ph. D. Thesis. Aarhus University 1996.